Income Statement Nutrien Ltd.

Equities

NTR

CA67077M1086

Agricultural Chemicals

Market Closed - Toronto S.E. Other stock markets 16:00:00 2025-01-17 EST			5-day change	1st Jan Change
74.60 ^CAD	+0.59%		+6.71%	+15.98%

01-16	Morningstar Financial Research on Nutrien	MT
01-14	Oppenheimer Initiates Coverage of Nutrien With an Outperform Rating, US$60.00 Price Target	MT

b9.AeJFY_FBxR4vtWntO8viRAiqq0kjl4gq9VHakZePN_4.WaUMO7MQp2Zd_V-MVZS0dHKanyNO7cMatjmYw6LjdpNgkBIvxA6WfGHUMA

Published financial data: NUTRIEN LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	19.26B	20.05B	26.86B	37.01B	28.08B
Total Revenues	19.26B	20.05B	26.86B	37.01B	28.08B
Cost of Goods Sold, Total	13.81B	14.81B	17.45B	21.59B	19.61B
Gross Profit	5.44B	5.24B	9.41B	15.42B	8.47B
Selling General & Admin Expenses, Total	2.92B	3.26B	3.63B	3.99B	4.03B
Stock-Based Compensation (IS)	104M	69M	198M	63M	-14M
Other Operating Expenses	372M	393M	737M	1.53B	907M
Other Operating Expenses, Total	3.4B	3.72B	4.56B	5.58B	4.92B
Operating Income	2.04B	1.52B	4.85B	9.84B	3.55B
Interest Expense, Total	-490M	-475M	-479M	-484M	-726M
Interest And Investment Income	5M	1M	8M	25M	35M
Net Interest Expenses	-485M	-474M	-471M	-459M	-691M
Income (Loss) On Equity Invest.	66M	73M	89M	247M	101M
Currency Exchange Gains (Loss)	-42M	-18M	-42M	-31M	-91M
Other Non Operating Income (Expenses)	-54M	-33M	9M	-96M	-97M
EBT, Excl. Unusual Items	1.53B	1.07B	4.43B	9.5B	2.78B
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-98M	-60M	-43M	-46M	-49M
Gain (Loss) On Sale Of Investments	-	250M	-	19M	-
Gain (Loss) On Sale Of Assets	-	-6M	-	-	-
Asset Writedown	-120M	-824M	-33M	780M	-774M
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	-48M	-187M	-8M	-
EBT, Incl. Unusual Items	1.31B	382M	4.17B	10.25B	1.95B
Income Tax Expense	316M	-77M	989M	2.56B	670M
Earnings From Continuing Operations	992M	459M	3.18B	7.69B	1.28B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	992M	459M	3.18B	7.69B	1.28B
Minority Interest	-	-	-26M	-27M	-24M
Net Income - (IS)	992M	459M	3.15B	7.66B	1.26B
Net Income to Common Incl Extra Items	992M	459M	3.15B	7.66B	1.26B
Net Income to Common Excl. Extra Items	992M	459M	3.15B	7.66B	1.26B
Per Share Items
Net EPS - Basic	1.7	0.81	5.53	14.23	2.53
Basic EPS - Continuing Operations	1.7	0.81	5.53	14.23	2.53
Basic Weighted Average Shares Outstanding	582M	570M	570M	538M	496M
Net EPS - Diluted	1.7	0.81	5.52	14.18	2.53
Diluted EPS - Continuing Operations	1.7	0.81	5.52	14.18	2.53
Diluted Weighted Average Shares Outstanding	583M	570M	571M	540M	497M
Normalized Basic EPS	1.64	1.17	4.82	10.98	3.45
Normalized Diluted EPS	1.64	1.17	4.8	10.95	3.44
Dividend Per Share	1.76	1.8	1.84	1.92	2.12
Payout Ratio	103.02	224.4	33.14	13.46	82.03
Supplemental Items
EBITDA	3.61B	3.23B	6.49B	11.51B	5.33B
EBITA	2.3B	1.8B	5.16B	10.21B	3.9B
EBIT	2.04B	1.52B	4.85B	9.84B	3.55B
EBITDAR	3.67B	3.29B	6.57B	11.61B	5.44B
Effective Tax Rate - (Ratio)	24.16	-20.16	23.73	24.98	34.32
Total Current Taxes	139M	-68M	1.02B	2.38B	663M
Total Deferred Taxes	177M	-9M	-31M	182M	7M
Normalized Net Income	954M	669M	2.74B	5.91B	1.71B
Interest Capitalized	18M	20M	29M	37M	71M
Interest on Long-Term Debt	421M	426M	448M	368M	494M
Non-Cash Pension Expense	31M	16M	19M	16M	-67M
Supplemental Operating Expense Items
Selling and Marketing Expenses	2.5B	2.81B	3.14B	3.41B	3.4B
General and Administrative Expenses	404M	429M	477M	565M	626M
Research And Development Expense From Footnotes	15M	39M	69M	122M	114M
Net Rental Expense, Total	66M	60M	81M	93M	103M
Imputed Operating Lease Interest Expense	26.39M	21.15M	29.65M	34.04M	53.62M
Imputed Operating Lease Depreciation	39.61M	38.85M	51.35M	58.96M	49.38M
Stock-Based Comp., Other (Total)	104M	69M	198M	63M	-14M
Total Stock-Based Compensation	104M	69M	198M	63M	-14M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	671M	1.45B	499M	901M	941M
Total Cash And Short Term Investments	671M	1.45B	499M	901M	941M
Accounts Receivable, Total	3.05B	3.02B	4.7B	5.6B	4.67B
Other Receivables	495M	562M	661M	598M	730M
Total Receivables	3.54B	3.58B	5.37B	6.19B	5.4B
Inventory	4.98B	4.93B	6.33B	7.63B	6.34B
Prepaid Expenses	1.48B	1.5B	1.65B	1.62B	1.5B
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	10.66B	11.47B	13.85B	16.34B	14.17B
Gross Property Plant And Equipment	31.68B	33.12B	34.82B	37.22B	39.32B
Accumulated Depreciation	-11.34B	-13.46B	-14.8B	-15.46B	-16.86B
Net Property Plant And Equipment	20.34B	19.66B	20.02B	21.77B	22.46B
Long-term Investments	821M	562M	703M	843M	736M
Goodwill	11.99B	12.2B	12.22B	12.37B	12.11B
Other Intangibles, Total	2.43B	2.39B	2.34B	2.3B	2.22B
Deferred Tax Assets Long-Term	249M	242M	262M	448M	477M
Deferred Charges Long-Term	89M	89M	88M	104M	113M
Other Long-Term Assets, Total	226M	583M	479M	417M	461M
Total Assets	46.8B	47.19B	49.95B	54.59B	52.75B
Liabilities
Accounts Payable, Total	4.02B	4.42B	5.18B	5.8B	5.48B
Accrued Expenses, Total	670M	1.34B	1.74B	1.78B	1.45B
Short-term Borrowings	976M	159M	1.56B	2.14B	1.82B
Current Portion of Long-Term Debt	502M	14M	545M	542M	512M
Current Portion of Leases	214M	249M	286M	305M	327M
Current Income Taxes Payable	43M	48M	606M	899M	14M
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	2.71B	2.26B	2.53B	2.81B	2.53B
Total Current Liabilities	9.13B	8.48B	12.44B	14.28B	12.12B
Long-Term Debt	8.55B	10.05B	7.52B	8.04B	8.91B
Long-Term Leases	859M	891M	934M	899M	999M
Pension & Other Post Retirement Benefits	433M	454M	419M	319M	252M
Deferred Tax Liability Non Current	3.14B	3.15B	3.16B	3.55B	3.57B
Other Non Current Liabilities	1.81B	1.81B	1.77B	1.64B	1.69B
Total Liabilities	23.93B	24.83B	26.26B	28.72B	27.55B
Common Stock, Total	15.77B	15.67B	15.46B	14.17B	13.84B
Additional Paid In Capital	248M	205M	149M	109M	83M
Retained Earnings	7.1B	6.61B	8.19B	11.93B	11.53B
Comprehensive Income and Other	-251M	-119M	-146M	-391M	-296M
Total Common Equity	22.87B	22.36B	23.65B	25.82B	25.16B
Minority Interest	-	-	47M	45M	45M
Total Equity	22.87B	22.36B	23.7B	25.86B	25.2B
Total Liabilities And Equity	46.8B	47.19B	49.95B	54.59B	52.75B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	571M	570M	551M	499M	495M
ECS Total Common Shares Outstanding	573M	569M	557M	507M	495M
Book Value / Share	39.91	39.29	42.43	50.9	50.87
Tangible Book Value	8.46B	7.78B	9.09B	11.15B	10.82B
Tangible Book Value Per Share	14.76	13.67	16.31	21.99	21.89
Total Debt	11.1B	11.36B	10.85B	11.93B	12.57B
Net Debt	10.43B	9.91B	10.35B	11.03B	11.62B
Debt Equivalent of Unfunded Proj. Benefit Obligation	31M	-16M	-72M	-75M	-44M
Debt Equivalent Oper. Leases	528M	480M	648M	744M	824M
Minority Interest, Total (Incl. Fin. Div)	-	-	47M	45M	45M
Equity Method Investments, Total	660M	409M	459M	643M	482M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	615M	664M	823M	951M	884M
Inventories - Work In Process, Total	244M	227M	206M	184M	160M
Inventories - Finished Goods, Total	4.12B	4.04B	5.3B	6.5B	5.29B
Land - (BS)	1.47B	1.53B	1.55B	1.6B	1.63B
Buildings, Total	8.21B	8.38B	8.58B	8.8B	9.05B
Machinery, Total	18.55B	19.73B	20.63B	22.02B	23.24B
Full Time Employees	22.3K	23.1K	23.5K	24.7K	25.9K
Accumulated Allowance for Doubtful Accounts (Supple)	83M	69M	82M	95M	111M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	992M	459M	3.15B	7.66B	1.28B
Depreciation & Amortization - CF	1.54B	1.71B	1.64B	1.64B	1.83B
Amortization of Goodwill and Intangible Assets - (CF)	261M	283M	314M	368M	342M
Depreciation & Amortization, Total	1.8B	1.99B	1.95B	2.01B	2.17B
(Gain) Loss on Sale of Investments - (CF)	-	-250M	-	-19M	-
Asset Writedown & Restructuring Costs	120M	824M	33M	-780M	774M
(Income) Loss On Equity Investments - (CF)	-	-	-	-181M	117M
Stock-Based Compensation (CF)	104M	69M	198M	63M	-14M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	160M	-342M	212M	503M	231M
Change In Accounts Receivable	-64M	145M	-1.67B	-919M	879M
Change In Inventories	190M	85M	-1.46B	-1.28B	1.38B
Change In Accounts Payable	602M	354M	1.69B	938M	-1.75B
Change in Other Net Operating Assets	-238M	-10M	-227M	114M	-
Cash from Operations	3.66B	3.32B	3.89B	8.11B	5.07B
Capital Expenditure	-1.73B	-1.42B	-1.68B	-2.23B	-2.46B
Cash Acquisitions	-911M	-233M	-88M	-407M	-153M
Divestitures	-	-	-	-	-92M
Sale (Purchase) of Intangible assets	-163M	-126M	-107M	-211M	-206M
Investment in Marketable and Equity Securities, Total	-198M	438M	-	-	-
Other Investing Activities, Total	202M	140M	64M	-56M	-42M
Cash from Investing	-2.8B	-1.2B	-1.81B	-2.9B	-2.96B
Short Term Debt Issued, Total	216M	-	1.34B	529M	-
Long-Term Debt Issued, Total	1.51B	1.54B	86M	1.04B	1.5B
Total Debt Issued	1.73B	1.54B	1.43B	1.57B	1.5B
Short Term Debt Repaid, Total	-	-892M	-	-	-458M
Long-Term Debt Repaid, Total	-1.24B	-783M	-2.53B	-902M	-1.02B
Total Debt Repaid	-1.24B	-1.68B	-2.53B	-902M	-1.48B
Issuance of Common Stock	20M	-	200M	168M	33M
Repurchase of Common Stock	-1.93B	-160M	-1.04B	-4.52B	-1.05B
Common Dividends Paid	-1.02B	-1.03B	-1.04B	-1.03B	-1.03B
Common & Preferred Stock Dividends Paid	-1.02B	-1.03B	-1.04B	-1.03B	-1.03B
Other Financing Activities, Total	-29M	-15M	-21M	-20M	-34M
Cash from Financing	-2.48B	-1.34B	-3B	-4.73B	-2.06B
Foreign Exchange Rate Adjustments	-31M	3M	-31M	-76M	-7M
Net Change in Cash	-1.64B	783M	-955M	402M	40M
Supplemental Items
Cash Interest Paid	505M	498M	491M	482M	729M
Cash Income Tax Paid (Refund)	29M	156M	435M	1.88B	1.76B
Levered Free Cash Flow	1.07B	1.76B	1.76B	4.63B	1.64B
Unlevered Free Cash Flow	1.38B	2.06B	2.06B	4.93B	2.09B
Change In Net Working Capital	-88M	-599M	1.34B	855M	-388M
Net Debt Issued / Repaid	482M	-134M	-1.1B	672M	19M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	2.76	2.02	6.24	11.77	4.14
Return on Total Capital	3.77	2.81	8.87	17	5.88
Return On Equity %	4.2	2.03	13.79	31.02	5.02
Return on Common Equity	4.2	2.03	13.7	30.97	4.94
Margin Analysis
Gross Profit Margin %	28.26	26.13	35.03	41.67	30.18
SG&A Margin	15.19	16.23	13.51	10.77	14.34
EBITDA Margin %	18.73	16.12	24.16	31.11	18.99
EBITA Margin %	11.96	9	19.21	27.58	13.87
EBIT Margin %	10.6	7.59	18.04	26.59	12.65
Income From Continuing Operations Margin %	5.15	2.29	11.84	20.77	4.57
Net Income Margin %	5.15	2.29	11.74	20.7	4.48
Net Avail. For Common Margin %	5.15	2.29	11.74	20.7	4.48
Normalized Net Income Margin	4.95	3.33	10.21	15.97	6.09
Levered Free Cash Flow Margin	5.55	8.79	6.55	12.51	5.84
Unlevered Free Cash Flow Margin	7.14	10.27	7.66	13.33	7.45
Asset Turnover
Asset Turnover	0.42	0.43	0.55	0.71	0.52
Fixed Assets Turnover	0.98	1	1.35	1.77	1.27
Receivables Turnover (Average Receivables)	6.65	6.61	6.96	7.19	5.47
Inventory Turnover (Average Inventory)	2.79	2.99	3.1	3.09	2.81
Short Term Liquidity
Current Ratio	1.17	1.35	1.11	1.14	1.17
Quick Ratio	0.46	0.59	0.47	0.5	0.52
Operating Cash Flow to Current Liabilities	0.4	0.39	0.31	0.57	0.42
Days Sales Outstanding (Average Receivables)	54.91	55.36	52.48	50.79	66.7
Days Outstanding Inventory (Average Inventory)	130.69	122.36	117.73	118.01	130.01
Average Days Payable Outstanding	93	104.47	92.89	87.5	112.36
Cash Conversion Cycle (Average Days)	92.59	73.25	77.32	81.3	84.35
Long Term Solvency
Total Debt/Equity	48.55	50.79	45.77	46.12	49.86
Total Debt / Total Capital	32.68	33.68	31.4	31.56	33.27
LT Debt/Equity	41.16	48.91	35.68	34.56	39.33
Long-Term Debt / Total Capital	27.7	32.43	24.48	23.65	26.25
Total Liabilities / Total Assets	51.13	52.61	52.56	52.62	52.22